Healthcare Innovation Amid An Aging Population – Global X ETFs – 10.4.24

Healthcare Innovation Amid An Aging Population - Global X ETFs - 10.4.24

Overview:

Title: Healthcare Innovation Amid An Aging Population
Date: Friday, October 4, 2024
Time: 1:00 PM Eastern Daylight Time
Duration: 1 hour

Register Now:

Already Registered?
*I am a financial professional. I understand that this event is for financial professionals only, and I may be contacted by the sponsor.

Summary:

The global population aged 65 and older is projected to double by 2050. The global demographic shift towards an older population is driving rapid advancements in healthcare.

Key topics we will discuss:

  • GLP-1 treatments, like Ozempic and Mounjaro, have become household names. Their success in treating type 2 diabetes and obesity may pave the way for applications in age-related illnesses.
  • Growing healthcare needs will require an expanded medical toolkit. 2023 saw breakthroughs in genomic medicines, including gene therapy and editing. New manufacturing standards could reduce production costs by up to 95%, improving accessibility.
  • Artificial intelligence is poised to revolutionize healthcare, with numerous applications in patient care that could help scale the industry.

Accepted for 1 CFP® / IWI / CFA CE Credit

Speaker:

Arelis Agosto Arelis Agosto Director of Research & Strategy Global X ETFs

Arelis (Lis) is the Director of Research & Strategy at Global X, where she leads research initiatives across the company’s full product lineup. She has been with Global X since 2022, where she started as a Research Analyst covering healthcare-related funds in the Thematic Growth suite. Prior to joining Global X, she worked as a Senior Healthcare Analyst at Third Bridge, focusing on U.S. life sciences, diagnostics, biotech, pharmaceutical services, and animal health. Lis holds a BA from Babson College in Business, with a concentration in Global Businesses Management.